HealthcareServices

Artificial Intelligence In Life Sciences Market Outlook 2026–2035: Growth Drivers and Industry Forecast

March 2, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the artificial intelligence in life sciences market from 2026–2035 with trusted insights from The Business Research Company

Starting from its 2026 valuation, what market size is the Artificial Intelligence In Life Sciences Market expected to reach by 2030?

The artificial intelligence in life sciences market has experienced substantial expansion in recent years. It is forecast to increase from $3.59 billion in 2025 to $4.44 billion in 2026, achieving a compound annual growth rate (CAGR) of 23.6%. This historical growth was driven by several key factors, including the escalating complexity of biological datasets, the broadening of genomics research, the increasing embrace of digital lab technologies, the early incorporation of AI in biotechnology research, and a growing demand for accelerated research cycles.

The artificial intelligence in life sciences market is poised for significant expansion over the coming years, with its size projected to reach $10.43 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 23.8%. This anticipated growth throughout the forecast period is primarily driven by factors such as heightened investments in personalized medicine, the increasing implementation of AI-enabled laboratory automation, the widening availability of cloud-based life science platforms, stronger partnerships between technology and life science companies, and a greater regulatory receptiveness towards AI-derived insights. Dominant trends emerging during this timeframe encompass a more extensive integration of AI across various life science workflows, the increasing uptake of AI-powered data analytics platforms, a greater reliance on automation in laboratory operations, the expansion of AI-based precision medicine applications, and a sharpened focus on expediting research outcomes.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13587&type=smp

What Drivers Are Driving Adoption Within The Artificial Intelligence In Life Sciences Market?

The increasing appeal of real-time remote patient monitoring (RPM) systems is projected to drive the expansion of the artificial intelligence in the life sciences market in the future. A remote patient monitoring system represents a technology-driven healthcare solution developed to oversee patients’ well-being outside of traditional medical facilities. AI in life sciences significantly supports remote patient monitoring by delivering continuous, personalized, and data-driven insights that facilitate proactive healthcare management. For instance, in April 2025, the Peterson Center on Healthcare, a US-based non-profit organization, reported that expenditure for remote therapeutic monitoring (RTM) in Traditional Medicare rose from $2.2 million in 2022 to $10.4 million in 2023. Additionally, in 2023, 451,000 patients in Traditional Medicare used RPM services. Therefore, the growing interest in real-time remote patient monitoring (RPM) systems is fueling the growth of artificial intelligence in the life sciences market.

How Is The Artificial Intelligence In Life Sciences Market Organized Into Various Segments?

The artificial intelligence in life sciences market covered in this report is segmented –

1) By Offering: Software, Hardware, Services

2) By Deployment: On-Premises, Cloud-Based

3) By Application: Drug Discovery, Medical Diagnosis, Biotechnology, Clinical Trials, Precision And Personalized Medicine, Patient Monitoring

Subsegments:

1) By Software: Drug Discovery Software, Genomic Analysis Software, Clinical Trial Management Software, Personalized Medicine Software, Laboratory Information Management Systems (LIMS)

2) By Hardware: AI-Enabled Laboratory Equipment, Robotics And Automation Systems, Imaging Devices And Equipment, Sensor Technologies

3) By Services: Consulting Services, Data Analytics Services, Research And Development Services, Implementation And Integration Services, Training And Support Services

Which Market Trends Are Opening Growth Opportunities In The Artificial Intelligence In Life Sciences Market?

Leading companies in the artificial intelligence in the life sciences market are prioritizing advanced products with technological innovations, such as drug discovery software, to maintain their market position. Drug discovery software comprises computer programs and applications specifically designed to support pharmaceutical and biotechnology researchers in the process of discovering new medications. For example, in December 2023, Merck, a Germany-based science and technology company, introduced AIDDISON, a revolutionary drug discovery software. Being the first of its kind, it integrates virtual molecule design with real-world manufacturability through the use of generative AI, machine learning, and computer-aided drug design. AIDDISON adeptly identifies drug candidates from a wide range of possibilities, while evaluating essential attributes like non-toxicity and solubility. This capability to bridge the divide between theoretical molecule design and practical manufacturability showcases a significant application of artificial intelligence in the life sciences sector.

Who Are The Top-Performing Companies In The Artificial Intelligence In Life Sciences Market In Recent Years?

Major companies operating in the artificial intelligence in life sciences market are Google LLC, Microsoft Corporation, Intel Corporation, IBM Corporation, Medtronic PLC, Nvidia Corporation, Novo Nordisk A/S, Siemens Healthineers AG, Philips Healthcare, Babylon Healthcare Services Ltd., Komodo Health Inc., Modernizing Medicine Inc., Viz.ai Inc., Butterfly Network Inc., Augmedix, AiCure LLC, HealthTap Inc., Welltok Inc., Enlitic Inc., PathAI Inc., Nano-X Imaging Ltd., Berg LLC, Insitro, Sense.ly Inc., Subtle Medical Inc., Medasense Biometrics Limited, Immunai, Atomwise Inc., Freenome Holdings Inc., CloudMedX Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-life-sciences-global-market-report

Which Region Currently Holds The Largest Share Of The Artificial Intelligence In Life Sciences Market?

North America was the largest region in the Artificial Intelligence In Life Sciences market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in life sciences market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Artificial Intelligence In Life Sciences Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13587&type=smp

Browse Through More Reports Similar to the Global Artificial Intelligence In Life Sciences Market 2026, By The Business Research Company

Life Science Analytics Market Report 2026

https://www.thebusinessresearchcompany.com/report/life-science-analytics-global-market-report

Ai In Life Science Analytics Market Report 2026

https://www.thebusinessresearchcompany.com/report/ai-in-life-science-analytics-global-market-report

Artificial Intelligence In Medicine Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-medicine-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795